Shire Plc has reached an agreement to acquire substantially all of the assets of privately-held Pervasis Therapeutics Inc of Cambridge, Massachusetts which has a clinical-stage, cell-based therapy for enhancing blood vessel repair. ---Subscribe to MedNous to access this article--- Company News Regenerative Medicine
